Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jun;2(2):223-226.
doi: 10.1093/ecam/neh086. Epub 2005 Apr 20.

Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa)

Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa)

Sachiko Tsukamoto et al. Evid Based Complement Alternat Med. 2005 Jun.

Abstract

Recent investigation on drug interaction has shown that some foods and herbal medicines increase the oral availability of a variety of CYP3A4 substrates, which is caused by the reduction of CYP3A4 in intestinal epithelium. During the course of our investigation on CYP3A4 interaction, we found that the commercially available dietary supplement made from black cohosh (Cimicifuga racemosa) showed CYP3A4 inhibition. Black cohosh has been used for the treatment of menopausal and post-menopausal symptoms as a dietary supplement. Bioassay-guided isolation from the supplement afforded six active principles, which were identified as cycloartanoid triterpene glycosides.

PubMed Disclaimer

Figures

<b>Figure 1</b>
Figure 1
Structures of CYP inhibitors isolated from C. racemosa

Similar articles

Cited by

References

    1. New Medicinal College of Jiangsu (ed.). Shanghai: Shanghai Scientific and Technological Press; 1977. Dictionary of Chinese Materia Medica; p. 451.
    1. Lieberman S. A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause. J Women's Health. 1998;7:525–29. - PubMed
    1. McKenna D, Jones K, Humphrey S, Hughes K. Black cohosh: efficacy, safety, and use in clinical and preclinical applications. Altern Ther. 2001;7:93–100. - PubMed
    1. Borrelli F, Izzo AA, Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sci. 2003;73:1215–29. - PubMed
    1. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 1996;6:1–42. - PubMed

LinkOut - more resources